BACKGROUND: PCR detects clonal rearrangements of the Ig gene in lymphoproliferative disorders. False negativity occurs in germinal centre/post-germinal centre lymphomas (GC/PGCLs) as they display a high rate of somatic hypermutation (SHM), which causes primer mismatching when detecting Ig rearrangements by PCR. AIMS: To investigate the degree of SHM in a group of GC/PGCLs and assess the rate of false negativity when using BIOMED-2 PCR when compared with previously published strategies. METHODS: DNA was isolated from snap-frozen tissue from 49 patients with GC/PGCL (23 diffuse large B cell lymphomas (DLBCLs), 26 follicular lymphomas (FLs)) and PCR-amplified for complete (VDJH), incomplete (DJH) and Ig kappa/lambda rearrangements using the BIOMED-2 protocols, and compared with previously published methods using consensus primers. Germinal centre phenotype was defined by immunohistochemistry based on CD10, Bcl-6 and MUM-1. RESULTS: Clonality detection by amplifying Ig rearrangements using BIOMED-2 family-specific primers was considerably higher than that found using consensus primers (74% DLBCL and 96% FL vs 69% DLBCL and 73% FL). Addition of BIOMED-2 DJH rearrangements increased detection of clonality by 22% in DLBCL. SHM was present in VDJH rearrangements from all patients with DLBCL (median (range) 5.7% (2.5-13.5)) and FL (median (range) 5.3% (2.3-11.9)) with a clonal rearrangement. CONCLUSIONS: Use of BIOMED-2 primers has significantly reduced the false negative rate associated with GC/PGCL when compared with consensus primers, and the inclusion of DJH rearrangements represents a potential complementary target for clonality assessment, as SHM is thought not to occur in these types of rearrangements.
BACKGROUND: PCR detects clonal rearrangements of the Ig gene in lymphoproliferative disorders. False negativity occurs in germinal centre/post-germinal centre lymphomas (GC/PGCLs) as they display a high rate of somatic hypermutation (SHM), which causes primer mismatching when detecting Ig rearrangements by PCR. AIMS: To investigate the degree of SHM in a group of GC/PGCLs and assess the rate of false negativity when using BIOMED-2 PCR when compared with previously published strategies. METHODS: DNA was isolated from snap-frozen tissue from 49 patients with GC/PGCL (23 diffuse large B cell lymphomas (DLBCLs), 26 follicular lymphomas (FLs)) and PCR-amplified for complete (VDJH), incomplete (DJH) and Ig kappa/lambda rearrangements using the BIOMED-2 protocols, and compared with previously published methods using consensus primers. Germinal centre phenotype was defined by immunohistochemistry based on CD10, Bcl-6 and MUM-1. RESULTS: Clonality detection by amplifying Ig rearrangements using BIOMED-2 family-specific primers was considerably higher than that found using consensus primers (74% DLBCL and 96% FL vs 69% DLBCL and 73% FL). Addition of BIOMED-2 DJH rearrangements increased detection of clonality by 22% in DLBCL. SHM was present in VDJH rearrangements from all patients with DLBCL (median (range) 5.7% (2.5-13.5)) and FL (median (range) 5.3% (2.3-11.9)) with a clonal rearrangement. CONCLUSIONS: Use of BIOMED-2 primers has significantly reduced the false negative rate associated with GC/PGCL when compared with consensus primers, and the inclusion of DJH rearrangements represents a potential complementary target for clonality assessment, as SHM is thought not to occur in these types of rearrangements.
Authors: Andrea Albinger-Hegyi; Bernhard Hochreutener; Marie-Therese Abdou; Ivan Hegyi; María Teresa Dours-Zimmermann; Michael O Kurrer; Philipp U Heitz; Dieter R Zimmermann Journal: Am J Pathol Date: 2002-03 Impact factor: 4.307
Authors: D González; A Balanzategui; R García-Sanz; N Gutiérrez; C Seabra; J J M van Dongen; M González; J F San Miguel Journal: Leukemia Date: 2003-07 Impact factor: 11.528
Authors: Walter J F M van der Velden; Loes Nissen; Marieke van Rijn; Jos Rijntjes; Anton de Haan; Lakshmi Venkatraman; Mark Catherwood; Hongxiang Liu; Hesham El-Daly; Lisette van de Laar; Moniek H C Craenmehr; J Han J M van Krieken; Wendy B C Stevens; Patricia J T A Groenen Journal: Haematologica Date: 2014-12-19 Impact factor: 9.941
Authors: María García-Álvarez; Sara Alonso-Álvarez; Isabel Prieto-Conde; Cristina Jiménez; M Eugenia Sarasquete; M Carmen Chillón; Alejandro Medina; Ana Balanzategui; Rebeca Maldonado; Alicia Antón; Noemí Puig; Marta Rodríguez; Oscar Blanco; Pilar Tamayo; Verónica González-Calle; Alejandro Martín; Ramón García-Sanz; Marcos González; M Dolores Caballero; Miguel Alcoceba Journal: Blood Cancer J Date: 2019-06-17 Impact factor: 11.037